69 citations,
October 2013 in “Journal of Clinical Psychopharmacology” This study investigated the effectiveness of naltrexone, an opioid antagonist, in treating trichotillomania (TTM) in 51 adults over an 8-week, double-blind trial. While naltrexone did not significantly reduce hair pulling compared to placebo, it did improve cognitive flexibility (P = 0.026). Additionally, participants with a family history of addiction showed a greater, though not statistically significant, reduction in hair-pulling urges. The findings suggested that future research should explore the potential of targeting the opiate system for managing TTM in specific subgroups.
183 citations,
January 1987 in “British Journal of Anaesthesia” Opioid painkillers can cause many side effects, including breathing problems and addiction, but are generally considered safe when used properly.
4 citations,
October 1998 in “In Practice” The conclusion is to thoroughly test for causes of cat hair loss and treat accordingly, considering medication only after serious conditions are ruled out.
1 citations,
February 2023 in “Daehan ui'sa hyeobhoeji/Daehan uisa hyeopoeji” Primary healthcare clinics are key in managing chemotherapy side effects using various medications and treatments.
November 2022 in “Journal of the Endocrine Society” Long-term treatment with buprenorphine/naloxone for opioid addiction may lead to secondary adrenal insufficiency.